BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117694
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117694
Table 4 Univariate and multivariate analysis of prognostic variables for T downstaging
VariablesUnivariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
Age1.0110.975-1.0470.553
Maximum diameter of the tumor0.9860.953-1.0210.417
Length0.9900.970-1.0110.333
Short diameter of the largest lymph node0.9470.876-1.0230.158
Maximum diameter perpendicular to the intestinal wall on T2WI1.0340.980-1.0990.252
Maximum cross-sectional area of the tumor on T2WI1.0000.999-1.0000.27
Distance of the tumor from the anal verge0.9940.982-1.0060.289
Carcinoembryonic antigen0.9980.994-1.0010.245
Carbohydrate antigen 19-91.0001.000-1.0010.828
Body mass index1.0770.931-1.2490.32
Sex2.0830.822-6.0360.143
Circle1.4510.778-2.6530.229
Signal0.6030.250-1.3820.243
Spiculation1.1410.507-2.5620.748
Node1.0190.430-2.5650.968
Stratification1.2690.551-2.8700.569
MRF status4.4561.881-11.5320.0013.4091.038-12.3690.049
Extramural vascular invasion status1.2250.539-2.7560.623
ExtraMRF1.4510.621-3.6210.403
Clinical T stage4.9282.170-12.3400.0001.7050.461-6.3690.421
Clinical N stage0.7820.464-1.2950.345
Sarcopenia1.0350.425-2.7160.941


Write to the Help Desk